SARS CoV 2 News and Research

RSS

Is sex safe during COVID-19 pandemic?

It is not unimaginable that with so many couples locked down within the confines of their homes 24/7, that close physical proximity could result in increased sexual activity, giving rise to questions regarding how safe sex is during these troubled times. COVID-19 disease or infection with the SARS-CoV-2 virus has gripped the world and has taken the form of a pandemic affecting 175 nations and territories across the globe.

26 Mar 2020

New research initiative to investigate multi-species response to novel coronavirus

Scientists at Texas Biomedical Research Institute (Texas Biomed) today announced the launch of a comprehensive research initiative to investigate multiple animal species and their response to the novel coronavirus disease (COVID-19).

26 Mar 2020

Stanford scientists describe potential transmission pathways of COVID-19

Much remains unknown about how SARS-CoV-2, the virus that causes COVID-19, spreads through the environment.

26 Mar 2020

A quest to unlock the genetic code of SARS-CoV-2

How the novel coronavirus that causes COVID-19 made the leap from animals to humans is a puzzle that scientists are trying to solve as humanity comes to grip with the deadly pandemic sweeping the globe.

26 Mar 2020

Frontiers launches Coronavirus Funding Monitor for the research community

Frontiers is dedicating part of its open science platform infrastructure to collect and disseminate information relevant to the research communities battling the COVID-19 pandemic using its Coronavirus Knowledge Hub.

26 Mar 2020

Anteater-like animals are the missing link for coronavirus transmission between bats and humans

As scientists scramble to learn more about the SARS-CoV-2 coronavirus, two recent studies of the virus' genome reached controversial conclusions: namely, that snakes are intermediate hosts of the new virus, and that a key coronavirus protein shares "uncanny similarities" with an HIV-1 protein.

26 Mar 2020

Berkeley Lights Announces GEPAD to Attack COVID-19 and Other Viruses

Today Berkeley Lights, Inc., announced the GEPAD with the aim to accelerate the discovery of neutralizing antibodies from patient blood samples.

From Bruker Cellular Analysis 26 Mar 2020

Murdoch Children's Research Institute to roll-out clinical trial of BCG vaccine against COVID-19

Professor Kathryn North AC, Director of the Murdoch Children's Research Institute in Melbourne, Australia, has announced its infectious disease researchers are preparing to roll-out a multi-center randomized controlled clinical trial of the BCG vaccine against COVID-19.

26 Mar 2020

FDA provides emergency use authorization to PerkinElmer for COVID-19 testing

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, announced today that the U.S. Food and Drug Administration (FDA) has provided Emergency Use Authorization (EUA) for the Company’s New Coronavirus RT-PCR test.

From Revvity 26 Mar 2020

What happens when COVID-19 and cardiovascular diseases mix?

The world has been brought to a stand-still by the COVID-19 pandemic that has affected 197 countries, areas and territories, infected 467,594, and killed 21,181 individuals as of today. COVID-19 disease is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a single-stranded RNA virus, contagious in humans.

25 Mar 2020

Transmission of COVID-19 among cancer patients in China

Researchers from Zhongnan Hospital of Wuhan University in China in collaboration with those from the National Cancer Centre Singapore, have come up with a study that reveals the transmission of the SARS-CoV-2 or novel coronavirus among patients with cancer in China.

25 Mar 2020

Coronavirus is not mutating rapidly, hope for vaccine development

Despite the coronavirus infection numbers skyrocketing, there is still good news. A team of scientists found that the novel coronavirus is not mutating significantly, suggesting any vaccine developed to fight SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) would remain effective in the long term.

25 Mar 2020

Critical guidance to identify COVID-19 patients at risk of drug-induced sudden cardiac death

SARS-CoV-2, the virus that causes COVID-19, continues to spread, leading to more than 20,000 deaths worldwide in less than four months. Efforts are progressing to develop a COVID-19 vaccine, but it's still likely 12 to 18 months away.

25 Mar 2020

Challenges and options to counter coronavirus pandemic in Germany

The worldwide spread of the coronavirus SARS-CoV-2 and its associated respiratory disease COVID-19 proceeds at a highly dynamic pace.

25 Mar 2020

Gero uses AI platform to identify potential anti-COVID-19 drugs

Gero, the leader in AI-driven drug discovery, has used its AI platform to identify the potential anti-COVID-19 drugs. Six of them have been approved, three were withdrawn, and the other nine have been already tested in clinical trials for other indications.

25 Mar 2020

CELLINK starts reselling a real-time qPCR instrument

CELLINK has started reselling a qPCR instrument. The instrument uses a laboratory technique of molecular biology based on the polymerase chain reaction.

From CELLINK 25 Mar 2020

Social distancing could stop coronavirus in just 13 weeks

The coronavirus disease (COVID-19) global pandemic has rippled across the world, with nearly 423,000 people now infected. Many countries have imposed lockdowns and strict quarantine measures to prevent the spread of the deadly virus.

25 Mar 2020

COVID-19 Global Rheumatology Alliance launches registry to get data on rheumatic disease patients

Today, the COVID-19 Global Rheumatology Alliance launched an international registry to help collect data that will be used to guide rheumatology clinicians and health professionals as they assess and treat rheumatic disease patients who are, or may become, infected with the SARS-CoV-2 virus that causes COVID-19.

25 Mar 2020

New modeling study estimates impact of physical distancing in reducing SARS-CoV-2 spread

A new modeling study conducted in a simulated Singapore setting has estimated that a combined approach of physical distancing interventions, comprising quarantine (for infected individuals and their families), school closure, and workplace distancing, is most effective at reducing the number of SARS-CoV-2 cases compared with other intervention scenarios included in the study.

25 Mar 2020

Africa prepares for lockdown as COVID-19 situation worsens

Like most other continents, Africa is affected by the novel coronavirus causing COVID-19. African nations are gearing up to curb the spread of the infection by imposing travel bans and lockdowns for the populations. The picture today looks grim, but steps are being taken to address the pandemic in Africa.

24 Mar 2020